SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-068998
Filing Date
2018-11-16
Accepted
2018-11-16 16:03:03
Documents
3
Period of Report
2018-11-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40284_18k.htm 8-K 31526
2 EX-2.1 a18-40284_1ex2d1.htm EX-2.1 276508
3 EX-99.1 a18-40284_1ex99d1.htm EX-99.1 222252
  Complete submission text file 0001104659-18-068998.txt   531451
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 181189856
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1